Canoe Financial LP Has $56.71 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Canoe Financial LP lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 29.1% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 164,123 shares of the company’s stock after selling 67,471 shares during the quarter. Canoe Financial LP’s holdings in HCA Healthcare were worth $56,713,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the stock. Sanders Capital LLC raised its stake in HCA Healthcare by 1.0% in the 4th quarter. Sanders Capital LLC now owns 11,655,563 shares of the company’s stock worth $3,498,417,000 after purchasing an additional 116,826 shares in the last quarter. First Eagle Investment Management LLC raised its stake in HCA Healthcare by 0.5% in the 4th quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company’s stock worth $1,351,830,000 after purchasing an additional 23,177 shares in the last quarter. Geode Capital Management LLC raised its stake in HCA Healthcare by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company’s stock worth $1,159,882,000 after purchasing an additional 50,321 shares in the last quarter. Capital World Investors raised its stake in HCA Healthcare by 0.7% in the 4th quarter. Capital World Investors now owns 2,928,452 shares of the company’s stock worth $878,975,000 after purchasing an additional 19,121 shares in the last quarter. Finally, Norges Bank bought a new position in HCA Healthcare in the 4th quarter valued at about $840,286,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of the company’s stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the transaction, the chief operating officer now owns 12,646 shares in the company, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Up 0.1%

NYSE:HCA opened at $377.26 on Friday. The firm’s 50 day simple moving average is $362.30 and its 200 day simple moving average is $334.77. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company has a market cap of $90.76 billion, a PE ratio of 16.77, a P/E/G ratio of 1.30 and a beta of 1.49.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.75 by $0.70. The firm had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The company’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $5.36 EPS. On average, research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be given a $0.72 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.81%.

Analyst Ratings Changes

Several equities analysts have commented on HCA shares. Wall Street Zen raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a report on Monday, April 28th. Robert W. Baird reissued a “neutral” rating and issued a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Barclays set a $416.00 target price on shares of HCA Healthcare and gave the company an “overweight” rating in a report on Monday, June 2nd. Guggenheim started coverage on shares of HCA Healthcare in a report on Wednesday, April 9th. They set a “neutral” rating on the stock. Finally, Morgan Stanley set a $410.00 price target on shares of HCA Healthcare and gave the company an “equal weight” rating in a report on Monday, June 9th. Seven analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $392.47.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.